key: cord-0707301-x15k988t
authors: Abdelmaksoud, Ayman; Patil, Anant; Dursun, Recep; Temiz, Selami Aykut; Ayhan, Erhan; Goldust, Mohamad; Vestita, Michelangelo
title: Could isotretinoin be a protective agent against COVID‐19?: A dermatologist perspective
date: 2021-06-06
journal: J Cosmet Dermatol
DOI: 10.1111/jocd.14239
sha: 76cc5bc23ffd48d79a73f59ab1342957477d5d47
doc_id: 707301
cord_uid: x15k988t

Being a "trending" unique treatment for moderate-to-severe acne, isotretinoin (13-cis retinoic acid) (ISO) is currently considered by experts the first line treatment even for mild acne, unless there is an absolute contraindication. ISO was identified, among other retinoids, to inhibit SARS-CoV-2 replication in Vero E6 cells. Shoemark et al.1.

Intriguingly, no worsening of lung function has been reported in cystic fibrosis patients while on ISO; rather, there was an improvement in lung function with no secondary infection in one patient. 6 Following infection, SARS-CoV-2 could induce initial rapid loss of the mature lung alveolar epithelial program followed, later, by cellular toxicity and loss of alveolar facultative progenitors. Fauchère et al. 7 reported maturation of the lungs in a nonviable fetus of 22 weeks' gestational age following accidental maternal intake of 30 mg/day of ISO till delivery. The administration of ISO to the critically hospitalized COVID-19 patients may burdensome. The ISO administration via powder aerosol was demonstrated to achieve higher concentrations in the lungs than in the oral route. 8 Based on the findings of such preliminary reports, further well-designed studies to explore the benefits of ISO re-purposing in COVID-19 are warranted.

Molecular Simulations suggest Vitamins, Retinoids and Steroids as Ligands of the Free Fatty Acid Pocket of the SARS-CoV-2 Spike Protein*

Possible role of neuropilins in dermatological manifestations of SARS-CoV-2 infection

Outcome prediction by serum calprotectin in patients with COVID-19 in the emergency department

Is systemic isotretinoin use a risk factor for coronavirus disease 2019 (COVID-19)?

Isotretinoin in acne treatment during the coronavirus disease 2019 (COVID-19): A retrospective analysis of adherence to therapy and side effects

Improvement of cystic fibrosis during treatment with isotretinoin

Acceleration of lung maturation in a human fetus following maternal isotretinoin intake

Pulmonary availability of isotretinoin in rats after inhalation of a powder aerosol